Pancreatic Cancer Diagnosis Improved by AI Metabolomics
Pancreatic Cancer Diagnosis Improved by AI Metabolomics
Publish Date: 2026-03-09 06:16:00
Source Domain: www.technologynetworks.com
Pancreatic cancer has long been regarded by the medical community as the most challenging cancer to diagnose due to its insidious early symptoms and the lack of effective screening tools. Consequently, most patients are diagnosed at an advanced stage, resulting in a five-year survival rate of only approximately 13%.
To overcome this clinical stalemate, a powerful interdisciplinary alliance between National Taiwan University (NTU) Hospital and Academia Sinica has successfully developed PanMETAI, a high-performance diagnostic model. By innovatively integrating Artificial Intelligence (AI) and Nuclear Magnetic Resonance (NMR) metabolomics through liquid biopsy, this technology establishes a highly stable and globally scalable screening platform, marking a pivotal breakthrough in precision medicine.
This landmark study was led by Professor Yu-Ting Chang (Department of Internal Medicine, NTU Hospital), Assistant Research Fellow Chun-Mei Hu (Genomics Research Center, Academia Sinica), and Distinguished Research Fellow Chao-Ping Hsu (Institute of Chemistry, Academia Sinica).
The team seamlessly integrated NTU Hospital’s frontline clinical expertise with Academia Sinica’s cutting-edge research capabilities in basic science, metabolomics platforms, and theoretical computational science. Through deep cross-institutional and interdisciplinary collaboration, the team has successfully overcome traditional diagnostic bottlenecks, opening new horizons for global pancreatic cancer prevention and control.
Core Global Metabolomic Profiling: Transcending Single Biomarker Limitations
In contrast to current diagnostic strategies that rely on single or limited biomarkers, PanMETAI utilizes global metabolomic signals as its analytical foundation. Using a highly standardized NMR metabolomics platform, the research team can extract approximately 260,000 metabolic signals from just 500 microliters ($mu$L) of serum per subject. A deep learning model is then employed to…
